About sanofi-aventis Sanofi-aventis is among the worlds leading pharmaceutical businesses.

Availability online of the sanofi-aventis half-year financial statement for 2007 Sanofi-aventis announces that its half-year financial statement for 2007 is currently available. About sanofi-aventis Sanofi-aventis is among the world’s leading pharmaceutical businesses, ranking number 1 in European countries. Backed by way of a world-course R&D organisation, sanofi-aventis is certainly developing leading positions in seven main therapeutic areas: cardiovascular, thrombosis, oncology, metabolic illnesses, central nervous program, internal vaccines and medicine. Sanofi-aventis is outlined in Paris and in NY .Picture: Wikimedia Commons.. Breast cancer overdiagnosis issues for USA By Lynda Williams, Senior medwireNews Reporter Around a third of screening-detected breast cancers in US ladies in 2008 may have been overdiagnosed, suggests analysis published in THE BRAND NEW England Journal of Medication. US Surveillance, Epidemiology, and FINAL RESULTS data were used to determine the incidence of early – and late-stage breast cancers among women aged 40 years and older from the introduction of screening mammography in 1976 to 2008.